Trinity Biotech ADR buy StockNews.com
Start price
13.09.23
/
50%
€0.74
Target price
13.09.24
-
Performance (%)
-41.50%
End price
14.09.24
-
Summary
This prediction is currently being closed. Massive losses of -41.50% have been the result for the BUY prediction by StockNews_com. StockNews_com has a follow-up prediction for Trinity Biotech ADR where he still thinks Trinity Biotech ADR is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Trinity Biotech ADR | - | - | - |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten